Australia Markets open in 8 hrs 3 mins

PharmAust Limited (PAA.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0840-0.0040 (-4.55%)
At close: 04:10PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 3-9.68%
S&P500 52-week change 3-13.21%
52-week high 30.0980
52-week low 30.0600
50-day moving average 30.0848
200-day moving average 30.0793

Share statistics

Avg vol (3-month) 3116.25k
Avg vol (10-day) 378.74k
Shares outstanding 5316.91M
Implied shares outstanding 6N/A
Float 8197.76M
% held by insiders 137.22%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 330 Oct 2015

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -8.81%
Operating margin (ttm)-7.36%

Management effectiveness

Return on assets (ttm)-2.53%
Return on equity (ttm)-6.22%

Income statement

Revenue (ttm)5.7M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)69.10%
Gross profit (ttm)4.2M
EBITDA -254.6k
Net income avi to common (ttm)-501.92k
Diluted EPS (ttm)-211.8400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.06M
Total cash per share (mrq)0.01
Total debt (mrq)1.11M
Total debt/equity (mrq)14.34
Current ratio (mrq)2.88
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-473.7k
Levered free cash flow (ttm)-247.81k